StockNews.AI
RBGLY
StockNews.AI
3 days

Shareholders that lost money on Reckitt Benckiser Group plc(RBGLY) should contact Levi & Korsinsky about pending Class Action - RBGLY

1. A class action lawsuit against Reckitt Benckiser Group plc is announced. 2. Allegations involve securities fraud impacting Enfamil sales and legal exposure. 3. Investors can join the class action without out-of-pocket costs. 4. Lawsuit covers losses from January 2021 to July 2024. 5. Levi & Korsinsky has a strong track record in securities litigation.

5m saved
Insight
Article

FAQ

Why Bearish?

Pending litigation can lead to stock price decline due to investor concerns. Historically, class actions have negatively influenced stock prices, like in the case of Johnson & Johnson during similar litigation.

How important is it?

The ongoing legal issues can result in financial losses for investors and impact market perception. Given past trends, litigation of this nature can affect stock performance significantly.

Why Long Term?

Outcomes of lengthy class actions often take time to resolve. Stocks can remain volatile during lawsuits, leading to potential long-term financial impacts.

Related Companies

JNJPFEABBV
, /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/reckitt-benckiser-group-plc-lawsuit-submission-form?prid=159007&wire=4  RBGLY investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in Reckitt Benckiser Group plc during the relevant time frame, you have until August 4, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected]Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News